WHO Register of non-State actors

Disclaimer:

Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

Overview

Official name

The International Society of Radiographers and Radiological Technologists

Acronym (if applicable)

ISRRT

Short self description

The ISRRT aims to improve the standards of delivery and practice of medical imaging and radiation therapy throughout the world by acting as the international liaison organization for medical radiation technology and promoting quality patient care, education and research in the radiation medicine Sciences.

Website

http://www.isrrt.org

Web link to health relevant activities

Parent entity (if applicable)

The entity you represent is indicated as a parent of the following entities in the Register:

N / A

Date submitted

23 Nov 2024 11:42:09 AM

General information

Name

Official name

The International Society of Radiographers and Radiological Technologists

Acronym (if applicable)

ISRRT

Commonly used name (if applicable)

Names in other official languages (if applicable) Name Abbreviation

The International Society of Radiographers and Radiological Technologists

ISRRT

Former name

Short self description

Address Contact

Address 1

207 Providence Scuare Mill steet

Address 2

Address 3

Town/City

London

State/Region

Postal code

SE1 2EW

Country

United Kingdom of Great Britain and Northern Ireland (The)

Email (generic)

ceo@isrrt.org

Related links

Website

http://www.isrrt.org

Governance

Legal status

UK Charity

Year established

1962

Governance structure

Description of main decision making bodies (e.g. board, board of directors, executive board, executive committee, etc).

Name of body

Board of Managment

Composition and current list of members Name Function Affiliation

Napapong Pongnapang

President

Assistant Professor Faculty of medical technology, Mahidol university, Bangkok,Thailand

Philippe Gerson

Treasurer

Ex- Manager Radiographer/ Hotel Dieu Hospital/Paris

Hakon Hjemly

VP Europe Africa

Director for Professional Practice Norway Association of Radiographers

Alain Cromp

VP Americas

President AC-Consultant Quebec, Canada.

Check-Wee Tan

VP Asia-Astralasia

Principal radiotherapist, National University Cancer Institute, Singapore.

Tim Agadakos

Regional director Europe

Chief Radiographer, Member of Scientific Council, CT Clinical Lecturer of ERASMUS radiography students and West Attica University, Athens

Elizabeth Balongun

Regional Director Africa

Chief Radiographer Radiology Department National Orthopaedic Hospital Igbobi Lagos

Donna Long

Regional Director Americas

Director, Health Sciences Education Indiana University Health

Naoki Kodama

Regional director Asia-astralasia

Professor of Department of Radiological Technology, Faculty of Medical Technology, Niigata University of Health and Welfare in Niigata city, Japan

Yudthaphon Vicianin

Director of PR and Communication

Department of Radiological Technology, Faculty of Medical Technology, Mahidol University

Stephen Lacey

Director of Education

Tutor Radiographer - Medical Imaging Department (Monday – Wednesday) Allied Health Education Fellowship, Education Hub (Thursday & Friday) he Royal Children's Hospital Melbourne

Edward Chan

Director of Professional practice

Senior Radiographer, The University of Hong Kong Shenzhen Hospital

Functions

The Board is the executive managing body of the ISRRT and undertakes the business of the ISRRT.

Name of body

Composition and current list of members Name Function Affiliation

Functions

General Assembly

Does the entity have a General Assembly of members or a similar body?

Yes

Name

ISRRT Council Meeting

Composition

ISRRT Council meeting Consists of one delegate from each National Radiography Society -Member.
Each Council member has one vote. In case one country has more than one Society, only one vote per county is allowed.

Functions

The Governing Body of the Society. All the power of the ISRRT rests on the Council

Financial information

Latest available annual income (month/year)

From

January

2023

December

2023

Annual income (USD)

111,527

Latest available assets (month/year)

As of

December

2023

Total assets (USD)

1,112,848

Income sources (in USD)

Income source Income type

Private sector entities (including business associations)

Philanthropic foundations

NGOs, academic institutions

Government entities, intergovernmental organizations, including UN

General public, individuals

Total

Sales of goods and services *

18,382

Grants / Donations

1,170

In-kind donations

5,000

Membership fees

65,032

Investment income

21,943

Others

Total

46,495

65,032

111,527

* income from congresses / conferences should be listed under Sales of goods and services

Additional information

NOTE: supporting Document on Finances 2021 is on GBP currency.
Chesney's sisters donated according their will a sum of 200.000 USD as donation to the ISRRT, (2015)
This donation have been invested and the profit of that investment has formulated the Chesney's Award as part of the research Fund of the ISRRT.
A Chesney's award is announced avery year for a 2 years research project, at a sum of 5.000GBP.
further info at : https://www.isrrt.org/research-fund-0

Membership

Entity's members

Is the entity you represent membership based?

Yes

Overview of categories and their voting rights in the main governing body:

Total number Voting

Individuals

NGOs

Private sector entities

Philanthropic foundations

Academic institutions

Government entities

Intergovernmental organizations

Organizational Structure

Parent entity

In the register Registered Entity Entity Name

No data available

Yes

Legal status

Affiliated entities (or subsidiaries)

In the register Registered Entity Entity Name

No data available

Relations

Entity's membership in other entities

In the register Registered Entity Entity Name Type of membership

No data available

Members of the entity

In the register Registered Entity Member Name

No data available

Activities

Aims (or purposes, objectives) of the entity as they appear in its constitution or by-laws or equivalent document.

The object of the Society is the advancement of medical imaging and radiation therapy and in that regard it shall:
Advance the science and practices of medical imaging and radiation therapy and allied subjects by the promotion of improved standards of education and of research in the technical aspects of medical imaging, radiation therapy and radiation protection;
Make the results of research and experience in medical imaging, radiation therapy and radiation protection available to practitioners throughout the world; Create and hold funds which shall be available for furthering the objects of the Society whilst at the same time being a charitable organisation.

The activities of the entity are related to the following strategic priorities and outcomes of the current WHO's General Programme of Work:

Strategic objective 1: Respond to climate change, an escalating health threat in the 21st century.

Joint outcome 1.1. More climate-resilient health systems are addressing health risks and impacts.

Joint outcome 1.2. Lower-carbon health systems and societies are contributing to health and well-being.

Strategic objective 2: Address health determinants and the root causes of ill health in key policies across sectors.

Joint outcome 2.1. Health inequities reduced by acting on social, economic, environmental and other determinants of health.

Joint outcome 2.2. Priority risk factors for noncommunicable and communicable diseases, violence and injury, and poor nutrition, reduced through multisectoral approaches.

Joint outcome 2.3. Populations empowered to control their health through health promotion programmes and community involvement in decision-making.

Strategic objective 3: Advance the primary health care approach and essential health system capacities for universal health coverage.

Joint outcome 3.1. The primary health care approach renewed and strengthened to accelerate universal health coverage.

Joint outcome 3.2. Health and care workforce, health financing and access to quality-assured health products substantially improved.

Joint outcome 3.3. Health information systems strengthened and digital transformation implemented.

Strategic objective 4: Improve health service coverage and financial protection to address inequity and gender inequalities.

Joint outcome 4.1. Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance.

Joint outcome 4.2. Equity in access to sexual, reproductive, maternal, newborn, child, adolescent and older person health and nutrition services and immunization coverage improved.

Joint outcome 4.3. Financial protection improved by reducing financial barriers and out-of-pocket health expenditures, especially for the most vulnerable.

Strategic objective 5: Prevent, mitigate and prepare for risks to health from all hazards.

Joint outcome 5.1. Risks of health emergencies from all hazards reduced and impact mitigated.

Joint outcome 5.2. Preparedness, readiness and resilience for health emergencies enhanced.

Strategic objective 6: Rapidly detect and sustain an effective response to all health emergencies.

Joint outcome 6.1. Detection of and response to acute public health threats is rapid and effective.

Joint outcome 6.2. Access to essential health services during emergencies is sustained and equitable.

Additional information on the entity's activities

Workshop 1 QA and Risk management in medical imaging (Dakar-Senegal)
workshop 2 Justification of Practice and optimization of radiation Protection-Mombasa-Kenya
workshop 3 Workshop in radiation protection Sofia-Bulgaria
ISRRT World Congress - Bangkok December 2022 - Pre-Congress Workshop Bangkok - ‘The importance of Ethics in Radiological Protection – A Practical Perspective for Medical Imaging
ISRRT World Congress in Bangok December 2022
ISRRT World Congress in Hong kong, June 2024

Country presence

Countries where the entity has activities, members and regional offices / representatives:

Regions

Countries

Activities

Members

Offices / representatives

African Region

Region of the Americas

Eastern Mediterranean Region

European Region

South-East Asia Region

Western Pacific Region

Global

Disclosure & declaration

Tobacco/Arms related disclosure statement for non-State actors

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?

Yes

No

Unable to answer

To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.

Yes

No

Unable to answer

To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.

Yes

No

Unable to answer

If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.

By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.

Engagement with other industries affecting human health or affected by WHO norm and standards

Does the entity you represent have any formal association, affiliation or links with the following industry sectors?

If yes, please tick the box of the industry concerned and provide details in the space provided:

Alcohol

Chemical

Food and beverages

Health care

Guerbet

Pharmaceutical

Others

Please specify industry

WHO Secretariat reserves the right to request additional information from the entity you represent relevant to its engagement with WHO.

*Sexual Exploitation, Abuse and Harassment (SEAH) and Misconduct (abusive or fraudulent)

Entities engaging with WHO are expected to ensure that the conduct of their employees and any other persons engaged by them to perform any activities or to provide any services for WHO on behalf of the entities is consistent with the WHO standards of conduct. In particular, WHO has zero tolerance towards any form of sexual misconduct, which includes sexual exploitation, sexual abuse, sexual violence, and sexual harassment, and other types of abusive or fraudulent conduct. In the view of the forgoing, please confirm that your entity shall:

Take all reasonable and appropriate measures to prevent sexual misconduct as defined in WHO’s Policy on Preventing and Addressing Sexual Misconduct, and other types of abusive or fraudulent conduct as defined, respectively, in WHO’s Policy on Preventing and Addressing Abusive Conduct and in WHO’s Policy on Prevention, Detection and Response to Fraud and Corruption by any of its employees and by any other persons engaged by it to perform any activities or to provide any services for WHO on the entity’s behalf;

Promptly report to WHO’s Office of Internal Oversight Services (IOS) at investigation@who.int any actual or suspected misconduct, as defined by WHO in these Policies and of which the entity becomes aware;

Promptly communicate to IOS any measures that may be necessary or appropriate to protect the confidentiality and wellbeing of the alleged victim;

Promptly respond to any actual or suspected misconduct as defined by WHO in these Policies of which the entity becomes aware; and

To cooperate with IOS and keep IOS informed of the status and outcome of any measures of protection, corrections to operations, investigation, and disciplinary action taken against any perpetrator by the entity.

Date submitted